These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8649769)

  • 41. Effects of immortalization upon the induction of matrix metalloproteinases in rabbit synovial fibroblasts.
    Lin CW; Robbins PD; Georgescu HI; Evans CH
    Exp Cell Res; 1996 Feb; 223(1):117-26. PubMed ID: 8635483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of myogenesis by okadaic acid, an inhibitor of protein phosphatases, 1 and 2A, correlates with the induction of AP1.
    Park K; Chung M; Kim SJ
    J Biol Chem; 1992 May; 267(15):10810-5. PubMed ID: 1316910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase.
    Cavigelli M; Li WW; Lin A; Su B; Yoshioka K; Karin M
    EMBO J; 1996 Nov; 15(22):6269-79. PubMed ID: 8947050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dietary energy restriction, in part through glucocorticoid hormones, mediates the impact of 12-O-tetradecanoylphorbol-13-acetate on jun D and fra-1 in Sencar mouse epidermis.
    Przybyszewski J; Wang W; Au A; Perry C; Guetzko M; Koehler K; Birt DF
    Mol Carcinog; 2010 Jun; 49(6):592-602. PubMed ID: 20232358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opposing functions of ATF2 and Fos-like transcription factors in c-Jun-mediated myogenin expression and terminal differentiation of avian myoblasts.
    Daury L; Busson M; Tourkine N; Casas F; Cassar-Malek I; Wrutniak-Cabello C; Castellazzi M; Cabello G
    Oncogene; 2001 Nov; 20(55):7998-8008. PubMed ID: 11753683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcription factor AP1 is involved in basal and okadaic acid-stimulated activity of the human PRL promoter.
    Caccavelli L; Manfroid I; Martial JA; Muller M
    Mol Endocrinol; 1998 Aug; 12(8):1215-27. PubMed ID: 9717847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of synthesis and phosphorylation of nuclear protein factors that bind to the positive cis-acting element in the transcriptional activation of the CYP2B1/B2 gene by phenobarbitone in vivo.
    Nirodi CS; Sultana S; Ram N; Prabhu L; Padmanaban G
    Arch Biochem Biophys; 1996 Jul; 331(1):79-86. PubMed ID: 8660686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
    Chuĭkin IA; Lianguzova MS; Pospelov VA
    Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional interference between AP-1 and the vitamin D receptor on osteocalcin gene expression in human osteosarcoma cells.
    Jääskeläinen T; Pirskanen A; Ryhänen S; Palvimo JJ; Deluca HF; Mäenpää PH
    Eur J Biochem; 1994 Aug; 224(1):11-20. PubMed ID: 8076631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation of novel, transcriptionally active AP-1 binding sites: implications for cellular transformation.
    Hawker KL; Vass JK; Ozanne BW
    Oncogene; 1996 Jul; 13(2):283-92. PubMed ID: 8710367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phorbol ester treatment of human myometrial cells suppresses expression of oxytocin receptor through a mechanism that does not involve activator protein-1.
    Ball A; Wang JW; Wong S; Zielnik B; Mitchell J; Wang N; Stemerman MB; Mitchell BF
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E922-8. PubMed ID: 16757545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of differentiation and c-jun expression in human leukemic cells by okadaic acid, an inhibitor of protein phosphatases.
    Adunyah SE; Unlap TM; Franklin CC; Kraft AS
    J Cell Physiol; 1992 May; 151(2):415-26. PubMed ID: 1315324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of AP-1 in primary B lymphocytes by surface immunoglobulin requires de novo Jun-B synthesis.
    Tanguay DA; Dickinson JA; McManus BJ; Huo L; Rothstein TL; Chiles TC
    Cell Immunol; 1994 Oct; 158(2):281-91. PubMed ID: 7923384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Okadaic acid, a phosphatase inhibitor, enhances the phorbol ester-induced interleukin-1 beta expression via an AP-1-mediated mechanism.
    Hurme M; Matikainen S
    Scand J Immunol; 1993 Dec; 38(6):570-4. PubMed ID: 8256116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
    Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decline in the expression of IL-2 after trauma and changes in the nuclear transcription factors NFAT and AP-1.
    Luo Y; Liang H; Hu C; Xu X; Wang Z
    Chin Med J (Engl); 2002 Sep; 115(9):1348-51. PubMed ID: 12411110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin-like growth factor-I augments interleukin-8 promoter activity through induction of activator protein-1 complex formation.
    Kooijman R; Coppens A; Van den Keybus C
    Int J Biochem Cell Biol; 2006; 38(11):1957-64. PubMed ID: 16846747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impaired AP-1 dimers and NFAT complex formation in immature thymocytes during in vivo glucocorticoid-induced apoptosis.
    Wisniewska M; Pyrzynska B; Kaminska B
    Cell Biol Int; 2004; 28(11):773-80. PubMed ID: 15563399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX.
    Natoli G; Avantaggiati ML; Chirillo P; Costanzo A; Artini M; Balsano C; Levrero M
    Mol Cell Biol; 1994 Feb; 14(2):989-98. PubMed ID: 7507209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.